Top Markets
Coin of the day
Spencer Pharmaceutical Inc. Spencer Pharmaceutical Inc.

Spencer Pharmaceutical Inc.

SPPH
Clasificación en acciones #41284
Spencer Pharmaceutical Inc. is dedicated to pioneering drug delivery platforms... Spencer Pharmaceutical Inc. is dedicated to pioneering drug delivery platforms aimed at addressing neurological conditions. A core aspect of their expertise lies in the precise, controlled administration of existing therapeutic compounds for central nervous system disorders, such as Alzheimer's, Parkinson's disease, and various forms of brain cancer. Moreover, the company holds a proprietary slow-release drug delivery system, which is utilized for managing type-2 diabetes and arthritis, and holds promise for other medical applications. Its operations are predominantly located in North America and Europe. Spencer Pharmaceutical Inc. was established in 1998 and maintains its headquarters in Boston, Massachusetts.
Precio por acción
$0.0001
Última sincronización: 2026-08-11
Capitalización bursátil
$29.44K
Cambio (1 día)
0.00%
Cambio (1 año)
0.00%
País
US
Comercio Spencer Pharmaceutical Inc. (SPPH)

Categoría

Ratio P/S de Spencer Pharmaceutical Inc. (SPPH)
Ratio P/S al 2026 TTM: 0
Según los informes financieros más recientes y el precio de las acciones de Spencer Pharmaceutical Inc., el ratio P/S actual (TTM) es 0. Al final de 2026, el ratio P/S era 0.
Historial del ratio P/S de Spencer Pharmaceutical Inc. desde 2026 hasta 2026
Ratio P/S al final de cada año
Año Ratio P/S Cambiar
Not enough data for the provided dates.
Ratio P/S de empresas similares o competidoras